4-133150609-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032961.3(PCDH10):c.469C>A(p.Arg157Ser) variant causes a missense change. The variant allele was found at a frequency of 0.0000143 in 1,613,370 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000014 ( 0 hom. )
Consequence
PCDH10
NM_032961.3 missense
NM_032961.3 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 3.96
Genes affected
PCDH10 (HGNC:13404): (protocadherin 10) This gene belongs to the protocadherin gene family, a subfamily of the cadherin superfamily. This family member contains 6 extracellular cadherin domains, a transmembrane domain and a cytoplasmic tail differing from those of the classical cadherins. The encoded protein is a cadherin-related neuronal receptor thought to function in the establishment of specific cell-cell connections in the brain. This gene plays a role in inhibiting cancer cell motility and cell migration. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.042012036).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PCDH10 | NM_032961.3 | c.469C>A | p.Arg157Ser | missense_variant | 1/5 | ENST00000264360.7 | NP_116586.1 | |
PCDH10 | NM_020815.3 | c.469C>A | p.Arg157Ser | missense_variant | 1/1 | NP_065866.1 | ||
PCDH10 | XM_011532150.2 | c.469C>A | p.Arg157Ser | missense_variant | 1/5 | XP_011530452.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PCDH10 | ENST00000264360.7 | c.469C>A | p.Arg157Ser | missense_variant | 1/5 | 1 | NM_032961.3 | ENSP00000264360 | P1 | |
PCDH10 | ENST00000618019.1 | c.469C>A | p.Arg157Ser | missense_variant | 1/1 | ENSP00000480512 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151918Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
2
AN:
151918
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000108 AC: 27AN: 250222Hom.: 0 AF XY: 0.0000811 AC XY: 11AN XY: 135562
GnomAD3 exomes
AF:
AC:
27
AN:
250222
Hom.:
AF XY:
AC XY:
11
AN XY:
135562
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461452Hom.: 0 Cov.: 36 AF XY: 0.00000963 AC XY: 7AN XY: 727054
GnomAD4 exome
AF:
AC:
21
AN:
1461452
Hom.:
Cov.:
36
AF XY:
AC XY:
7
AN XY:
727054
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151918Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 74164
GnomAD4 genome
AF:
AC:
2
AN:
151918
Hom.:
Cov.:
30
AF XY:
AC XY:
0
AN XY:
74164
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
14
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.469C>A (p.R157S) alteration is located in exon 1 (coding exon 1) of the PCDH10 gene. This alteration results from a C to A substitution at nucleotide position 469, causing the arginine (R) at amino acid position 157 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;N
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D
REVEL
Benign
Sift
Benign
.;T
Sift4G
Benign
T;T
Polyphen
0.011
.;B
Vest4
MutPred
Gain of disorder (P = 0.0523);Gain of disorder (P = 0.0523);
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at